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The synapse has high energy demands, which increase during intense activity. 27 
Presynaptic ATP production depends on substrate availability and usage will 28 
increase during activity, which in turn could influence transmitter release and 29 
information transmission. We investigated transmitter release at the mouse calyx of 30 
Held synapse using glucose or lactate (10, 1 or 0 mM) as the extracellular substrates 31 
while inducing metabolic stress. High frequency stimulation (HFS) and recovery 32 
paradigms evoked trains of EPSCs monitored under voltage-clamp. Whilst 33 
postsynaptic intracellular ATP was stabilised by diffusion from the patch pipette, 34 
depletion of glucose increased EPSC depression during HFS and impaired 35 
subsequent recovery. Computational modelling of these data demonstrated a 36 
reduction in the number of functional release sites and slowed vesicle pool 37 
replenishment during metabolic stress, with little change in release probability. 38 
Directly depleting presynaptic terminal ATP impaired transmitter release in an 39 
analogous manner to glucose depletion. In the absence of glucose, presynaptic 40 
terminal metabolism could utilise lactate from the aCSF and this was blocked by 41 
inhibition of monocarboxylate transporters (MCT). MCT inhibitors significantly 42 
suppressed transmission in low glucose, implying that lactate is a presynaptic 43 
substrate. Additionally, block of glycogenolysis accelerated synaptic transmission 44 
failure in the absence of extracellular glucose, consistent with supplemental supply 45 
of lactate by local astrocytes. We conclude that both glucose and lactate support 46 
presynaptic metabolism and that limited availability, exacerbated by high intensity 47 
firing, constrains presynaptic ATP, impeding transmission through a reduction in 48 





Key Points  52 
 Synapses have high energy demands which increase during intense activity. 53 
We show that presynaptic terminals can utilize extracellular glucose or lactate 54 
to generate energy to maintain synaptic transmission.  55 
 Reducing energy substrates induces a metabolic stress: presynaptic ATP 56 
depletion impaired synaptic transmission through a reduction in the number of 57 
functional synaptic vesicle release sites and a slowing of vesicle pool 58 
replenishment, without a consistent change in release probability.  59 
 Metabolic function is compromised in many pathological conditions (e.g. 60 
stroke, traumatic brain injury and neurodegeneration). Knowledge of how 61 
synaptic transmission is constrained by metabolic stress, especially during 62 
intense brain activity will provide insights to improve cognition following 63 




Energy provision for synaptic transmission is crucial for cognition and the 68 
relationship between brain activity and local nutrient supply is exploited in fMRI 69 
imaging. Transmission of information across synapses requires high levels of energy 70 
to maintain ionic gradients, Ca2+ extrusion and vesicular recycling (Attwell and 71 
Laughlin, 2001; Harris et al., 2012), hence during periods of high activity an 72 
imbalance between energy generation and consumption may influence neuronal 73 
function and compromise information transmission. The study of neuronal 74 
metabolism is often based on primary cultures and pharmacological block of 75 
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glycolysis or mitochondrial respiration; but to understand energy constraints on 76 
information transmission a more physiological situation would be advantageous. 77 
Metabolic demand is not uniform and varies between brain regions, with the auditory 78 
pathway having some of the highest metabolic rates in the nervous system (Sokoloff 79 
et al., 1977). The calyx of Held/MNTB synapse in the auditory brainstem can sustain 80 
high frequency transmission at rates of over 300 Hz (Kopp-Scheinpflug et al., 2011). 81 
The density, proximity, and morphology of mitochondria close to the presynaptic 82 
active zone is consistent with high metabolic rates at the calyx of Held (Satzler et al., 83 
2002; Perkins et al., 2010). The large size of the calyx presynaptic terminal and its 84 
target onto single neurons in the medial nucleus of the trapezoid body (MNTB) 85 
allows access to both the pre- and postsynaptic compartments and makes it an ideal 86 
preparation for direct investigation of metabolic influence (see von Gersdorff & Borst, 87 
2002; Schneggenburger & Forsythe 2006).   88 
Glucose deprivation is well known to compromise synaptic transmission (Akasu et 89 
al., 1996; Calabresi et al., 1997; Izumi et al., 1997). The mechanisms through which 90 
energy depletion impairs presynaptic function are the subject of intense interest in 91 
terms of both basic science and the association with diabetes, aging and dementia 92 
(Duarte, 2015; Feinkohl et al., 2014). The brain as a whole, preferentially 93 
metabolises glucose to meet its energy demands, but the extent to which neurons 94 
use glucose directly and/or require lactate via the astrocyte-neuron lactate shuttle 95 
(ANLS) (Pellerin and Magistretti, 1994) is a matter of debate. Some recent studies 96 
have indicated that the lactate shuttle is required to maintain neuronal function 97 
(Nagase et al., 2014; Suzuki et al., 2011), while others have proposed that glucose is 98 
the primary neuronal energy source (Dienel, 2012; Simpson et al., 2007).  99 
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We have used the calyx of Held/MNTB synapse in an in vitro brain slice preparation 100 
to measure the contribution of energy substrates, glucose and lactate, in maintaining 101 
synaptic transmission. This configuration allows recording from both the presynaptic 102 
calyx and postsynaptic neuron, and also preserves the close association of a 103 
supporting glial cell with the synapse (Uwechue et al., 2012). The results show that 104 
at physiological concentrations, glucose was used directly by the terminal, but that 105 
lactate also contributed to the maintenance of normal synaptic transmission. Glucose 106 
depletion increased synaptic depression during high frequency stimulation (HFS) 107 
and impaired the subsequent recovery of EPSC amplitude. This effect of glucose 108 
depletion was mimicked by dialysing the presynaptic terminal with low ATP (0.1 109 
mM). Model-based analysis of the experimental data indicated that impairment in 110 
ATP availability causes a significantly greater decline in the size of the readily 111 
releasable vesicle pool (RRVP), with the RRVP failing to recover even after minutes 112 
of rest between HFS epochs. This suggests that the metabolic demand of vesicle 113 
recycling places constraints on synaptic function under metabolic stress. 114 
 115 
Materials and Methods 116 
Electrophysiology & live fluorescent imaging 117 
Experiments were performed in accordance with the Animals (Scientific Procedures) 118 
Act 1986, UK. Transverse brainstem slices (thickness: 250 µm for postsynaptic 119 
recording with synaptic stimulation and 120 µm for paired pre- and post-synaptic 120 
recordings) were prepared from male and female P13-18 CBA/Ca mice killed by 121 
decapitation. Slices containing the MNTB were prepared in an ice-cold high sucrose 122 
saline composed of (in mM); sucrose (250), KCl (2.5), NaHCO3 (26), NaH2PO4 123 
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(1.25), D-glucose (10), ascorbic acid (0.5), MgCl2 (4) and CaCl2 (0.1) saturated with 124 
95% O2 and 5% CO2. Slices recovered in oxygenated artificial cerebrospinal fluid 125 
(aCSF) for at least 1 h at 34 ○C. The aCSF was composed of (in mM); NaCl (125), 126 
NaHCO3 (26), KCl (2.5), NaH2PO4 (1.25), myo-inositol (3), D-glucose (10), MgCl2 (1), 127 
and CaCl2 (2). 128 
 129 
Whole-cell patch recordings were made from single slices held in a recording 130 
chamber at 33 ± 2 ○C and perfused at 1 ml/min with oxygenated aCSF. We 131 
performed either postsynaptic recordings, or paired recordings where we 132 
simultaneously patched both the presynaptic terminal and postsynaptic neuron. 133 
Glass recording pipettes had a resistance of 3-6 MΩ. Postsynaptic pipettes were 134 
filled with a whole-cell patch solution composed of (in mM) K-gluconate (97.5), KCl 135 
(32.5), HEPES (5), EGTA (5), NaCl (5), MgCl2 (1) and K2-ATP (2); presynaptic 136 
pipettes contained (in mM) K-gluconate (97.5), KCl (32.5), HEPES (10), EGTA (0.2), 137 
MgCl2 (1), Na-glutamate (10), Na-GTP (0.3). Stated voltages were not corrected for 138 
a liquid junction potential of -9 mV. 139 
 140 
Chemicals and drugs were purchased from Sigma-Aldrich unless specified. Other 141 
drugs were purchased as listed here: monocarboxylate transporter inhibitor AR-142 
C155858 (Tocris, 4960) FM1-43FX (Molecular Probes, cat. no. F35355) alpha-143 
Latrotoxin (Alomone, LSP-130) Bromophenol Blue (Acros, cat. no. 151340250). 144 
Drugs were applied by perfusion in the aCSF. 145 
 146 
MNTB neurons with calyceal inputs were visually identified using a Nikon Eclipse 147 
E600FN and a 60x DIC objective. Recordings were made using a Multiclamp 700B 148 
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amplifier and Clampex/Clampfit software (Molecular Devices) for data acquisition 149 
and analysis. Responses were digitised at 20 kHz and filtered at 10 kHz, and the 150 
whole-cell capacitance compensated. The mean series resistance was 16 MOhms 151 
(range 6-25 MOhms) and series resistance was compensated by 70 %.  152 
Experiments were interleaved between control and test conditions through the 153 
experiments and the Rs were similar for each data set.  Rs was checked prior to 154 
each 30s train and after the last recovery stimulation of each epoch throughout the 155 
20-35 minutes of recording. Recordings discarded if the series resistance changed 156 
by more than 20 %, or went above 25 MOhms. EPSCs were recorded from MNTB 157 
neurons voltage-clamped at a holding potential of -40 mV. A bipolar stimulating 158 
electrode was positioned at the midline to evoke action potentials in the axons 159 
projecting to the MNTB; high frequency stimulation (HFS; 100 Hz for 30s) was given, 160 
followed by 6 pulses over the subsequent 30s to probe the recovery (Figure 1B). 161 
This protocol was given 10 min after a change in the aCSF composition and then 162 
repeated at 5 min intervals (i.e. at 15, 20, 25 and 30 mins) in all unpaired 163 
experiments (see example in Figure 1 E & F). The stimulation voltage was twice the 164 
voltage threshold required to evoke an EPSC. Presynaptic terminals were voltage-165 
clamped at -80 mV and HFS (100 Hz for 2 s) and subsequent recovery pulses 166 
evoked using voltage ramps to mimic action potentials (Figure 5A). The HFS 167 
protocol was given 1-2 min after breaking into the presynaptic terminal and then 168 
repeated 5 min later. The peak EPSC was mediated by AMPAR, with little 169 
contribution from NMDAR at this age and potential (Steinert et al., 2010). AMPAR 170 
desensitization also had little or no impact on synaptic response amplitude at near 171 




Live imaging of slices was performed with slices perfused with aCSF containing 10 174 
mM glucose or zero glucose and with a stimulating electrode placed at the midline to 175 
give 4x HFS at 5 min intervals. FM1-43FX dye (10 μM) was applied 1 minute before 176 
the third (20 min) HFS and was present until 1 minute after the end of the stimulation 177 
to allow endocytosis of released vesicles and subsequent internalization of FM1-178 
43FX. Bromophenol Blue (BPB, 0.5 mM, Harata et al., 2006) was then perfused in 179 
the extracellular solution to quench residual FM-143FX fluorescence. Live imaging 180 
was performed at 2 Hz, immediately before and during the fourth (25 min) HFS using 181 
a Nikon water immersion objective (40x, NA 0.8), a Nikon HGFI mercury lamp, a 182 
470/40nm excitation filter, a 630/60nm emission filter and an Optimos sCMOS 183 
camera (Q-Imaging) controlled via Micro-Manager software (RRID:SCR_000415; 184 
Edelstein et al., 2014). Following the fourth HFS, α-Latrotoxin (Lat, 10 nM) was 185 
applied for 2 minutes to deplete the releasable pool before acquisition of a final 186 
image. Fluorescence values in Lat were used to normalise the total vesicular 187 
fluorescence, and fluorescence was quantified using Fiji (RRID:SCR_002285; 188 
Schindelin et al., 2012) terminals were analysed only if the rate of fluorescence loss 189 
was 5 times faster than photobleach measured at background regions.  190 
 191 
Analysis 192 
Prism software (RRID:SCR_002798) was used to fit the recovery curves to mean 193 
data, to perform t-tests, two-way ANOVA or two-way repeated measures (RM) 194 
ANOVAs (followed by Dunnett’s or Bonferroni post hoc tests, as appropriate). For 30 195 
s trains every 100th EPSC was analysed, and for the 2 s trains every 10th EPSC 196 
was analysed by two-way RM-ANOVA, due to the large number of EPSCs. Data are 197 
mean ± SEM with statistical confidence <0.05 (, presented as p, specific values). A 198 
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power calculation (1-, %) for statistical significant data indicates the probability that 199 
type II errors have been excluded (http://clincalc.com/stats/power.aspx). Sample 200 
size, n, is the number of electrophysiology recordings; all were from different animals 201 
except for the paired recordings, where the number of animals used is given in 202 
brackets. For imaging experiments n is the number of calyces. 203 
 204 
 205 
Western blot 206 
Protein immunoblots were conducted using standard methods.  Briefly, tissue 207 
samples were homogenised using a pestle homogeniser in RIPA buffer (150 mM 208 
sodium chloride, 1 % Triton X-100, 0.5 % sodium deoxycholate, 0.1 % SDS and 50 209 
mM Tris, pH 8.0) supplemented with Mini cOmplete and PhosStop protease and 210 
phosphatase inhibitors.  The resulting solution was sonicated and the protein 211 
concentration measured using a Bradford assay.  50 mg of total protein lysate was 212 
subjected to SDS-PAGE electrophoresis. Subsequently, proteins were transferred to 213 
nitrocellulose membrane and protein bands visualised in a FujiFilm LAS-3000 imager 214 
using primary antibodies, HRP-conjugated secondary antibodies and ECL reagents 215 
(Pierce, UK). 216 
 217 
Modelling 218 
A mathematical model of the EPSC amplitude in response to presynaptic action 219 
potentials (APs) at the calyx of Held was developed from a previously published 220 
model based on extensive experimental data (Meyer et al., 2001; von Gersdorff & 221 
Borst, 2002; Hennig et al., 2008). New model components are added to account for 222 
the effects of ATP depletion. All model components are described as follows. 223 
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The fraction of transmitter, T, released from the presynaptic terminal in response to a 224 
single AP arriving at time t, depends on the readily releasable vesicle pool (RRVP) 225 
occupancy, n, and the vesicle release probability, p: 226 
𝑇(𝑡) = 𝑛(𝑡). 𝑝(𝑡) 
Both the release probability and vesicle pool size are dynamic variables, allowing 227 
modelling of vesicle pool depletion, and facilitation and slow depression of release 228 
probability (Hennig et al., 2008). EPSC amplitude is assumed to be proportional to T. 229 
The RRVP size is modelled as a continuous normalised variable, 𝑛(𝑡), with 𝑛(𝑡) =230 
𝑛𝑚𝑎𝑥 corresponding to all available release sites containing a docked vesicle. 231 
Synaptic stimulation results in vesicle release and hence changes in the RRVP, as 232 






− ∑ 𝛿(𝑡 − 𝑡𝑗). 𝑝(𝑡). 𝑛(𝑡)
𝑗
 
APs arrive at times tj, resulting in vesicle release and depletion of the RRVP. The 234 
RRVP is replenished with time constant, r, from an effectively infinite reserve pool 235 
and may reach a maximum size nmax. During HFS r is small due to fast, activity-236 
dependent recovery (Hennig et al., 2008) and its initial value, r0 is obtained from 237 
fitting to the initial phase (0.5 s) of depression during stimulation. To model extra 238 
depression of the EPSC amplitude during HFS in zero glucose, r  is allowed to 239 
increase in value during the HFS (see below). During recovery, the replenishment 240 
rate at the end of the HFS, rH increases rapidly, with time constant d, to a slower 241 
background rate (larger time constant), rR , according to:  242 
𝜏𝑟(𝑡) = 𝜏𝑟𝐻 + (𝜏𝑟𝑅 − 𝜏𝑟𝐻) (1 − 𝑒
−t 𝜏𝑑⁄ )⁄ ] 
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The experimental data shows that glucose depletion results in a greater EPSC 243 
depression during HFS followed by recovery to a lower maximum EPSC amplitude, 244 
while the rate of recovery is not significantly slower. Two factors are used to capture 245 
this behaviour in the model. Firstly, the increased depression during HFS is modelled 246 
by increasing r during the HFS (thus slowing activity-dependent replenishment of 247 
the RRVP and so reducing n) according to a logistic function: 248 
𝜏𝑟(𝑡) = 𝜏𝑟0/[𝐴𝑛 + (1 − 𝐴𝑛) (1 + 𝑒
(𝑡−𝑡𝑛) 𝑘𝑛⁄ )⁄ ] 
where 𝐴𝑛 is the steady-state fractional increase in r reached following HFS (final r  249 
denoted rH), 𝑡𝑛 is the half-time increase, and 𝑘𝑛 determines the rate of the increase 250 
(larger kn means slower increase).  To model the recovery to a reduced EPSC 251 
amplitude, the maximum RRVP size, nmax=1 during HFS, is set to a lower value, 252 
nmax=nrec, during the recovery phase, implying a reduction in the number of functional 253 
release sites. 254 
Facilitation of release probability, p(t),  is modelled by increasing the release 255 
probability by the amount 𝑘𝑓 . (1 − 𝑝(𝑡)) after each presynaptic AP. Release 256 






+ ∑ 𝛿(𝑡 − 𝑡𝑗). 𝑘𝑓
𝑗
. (1 − 𝑝(𝑡)) 
The variable 𝑐(𝑡) (initialised to 𝑃0) accounts for a slow depression of p, underpinning 258 
the slow rundown in EPSC amplitude during long stimulations (Hennig et al., 2008). 259 
Each presynaptic AP reduces 𝑐(𝑡) by 𝑘𝑖 . 𝑐(𝑡) which then recovers to its resting value 260 








− ∑ 𝛿(𝑡 − 𝑡𝑗). 𝑘𝑖
𝑗
. 𝑐(𝑡) 
Automated non-linear curve fitting was used to fit simulated normalised EPSC 262 
amplitudes to experimentally obtained EPSCs during HFS followed by a recovery 263 
period.  Peak EPSC amplitudes were extracted from each experimental recording to 264 
give the data against which the model was optimised.  265 
Since the electrophysiological recordings only contain one stimulation frequency, 266 
one parameter value was fixed to reduce the degrees of freedom in the fitting: in 267 
these recording conditions, the facilitation fraction, 𝑘𝑓, balances somewhat the value 268 
of the facilitation time constant, f, so its value has been fixed to 0.03 and only f is 269 
identified.  270 
Parameter identification proceeded as follows: 271 
1. Parameters r0, p0, and f were identified from the first 0.5 s of HFS (other 272 
slower model components were not present). 273 
2. With the above parameter values fixed, the remaining parameters were 274 
identified from the remaining period of HFS (29.5 s) plus the recovery period. 275 
3. On entering recovery, the maximum RRVP size, nmax is set to a new value nrec 276 
which is identified from the final, recovered steady-state EPSC amplitude. 277 
All the simulations and the parameter identification procedure were implemented in 278 
Python 2.7. The model error was calculated as the sum-of squares difference 279 
between the model and mean experimental EPSC amplitudes at all stimulation time 280 
points. Parameter identification to minimise this error was done with the fmin function 281 
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of the scipy.optimize Python package. The model differential equations were 282 
numerically integrated with the odeint function of the scipy.integrate Python package. 283 
 284 
Results 285 
Impaired presynaptic function following glucose deprivation  286 
The aim was to manipulate energy supply selectively to the presynaptic terminal.  287 
The postsynaptic neuron was rendered independent of aCSF substrate availability 288 
by diffusion of ATP from the recording patch pipette (Figure 1A). Under control 289 
conditions slices were perfused with standard aCSF containing 10 mM glucose. The 290 
HFS paradigm (100 Hz, 30 s, i.e. 3000 evoked responses, Figure 1B) caused a 291 
profound depression of EPSC amplitude within 0.2 s in every case (Figure 1C, 292 
representative example) that continued at a slower rate throughout the continuing 30 293 
s of stimulation (e.g. Figure 3A). The EPSC amplitude fully recovered within 20 s of 294 
the end of the HFS (Figure 1D, same recording as 1C). This HFS was repeated in 295 
four cells, at 5 min intervals, with no significant change in the magnitude of EPSC 296 
depression or recovery over 30 min. Each 5 min cycle of HFS is referred to as an 297 
‘HFS epoch’. This reproducible cycle of EPSC depression and recovery is plotted in 298 
Figure 1E (filled circles for the first and last EPSCs in the HFS and open circles for 299 
the recovery phase).  300 
Depletion of energy substrate was achieved by switching to an aCSF containing zero 301 
glucose, Figure 1F shows the results of the HFS paradigm under this condition 302 
(Figure 1F). By the fourth epoch under the energy depleted condition, the EPSC 303 
amplitude was highly depressed (69.1 ± 7.9 % compared to 20.3 ± 12.6 % in 10 mM 304 
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glucose control). This observation is further analysed in Figure 2, where the raw and 305 
mean EPSC amplitudes for control (10 mM) and zero glucose conditions are plotted. 306 
After 20 min of zero glucose the EPSC amplitude had depressed by 89.2 ± 3.3 % 307 
(n=6) at the end of HFS, compared to 59.7 ± 5.9 % depression in controls with 10 308 
mM glucose (n=4, Figure 2A, 2B for raw and normalised data, respectively; example 309 
EPSC traces in Figure 2D). The EPSC depression at the start of the HFS was similar 310 
in both conditions. However, during the last 8 s of HFS the magnitude of the 311 
depression significantly increased in the zero glucose condition compared with 312 
control (two-way RM-ANOVA, interaction p<0.001, Bonferroni post hocs p<0.05 for 313 
last 8 s of HFS; Figure 2B; at 25 minutes EPSCs had depressed by 54 ± 6.0 % in 10 314 
mM glucose and 79.6 ± 5.5 % with 0 mM glucose; interaction p<0.001, Bonferroni 315 
post hocs p<0.05 for last 8 s of HFS, power = 88.4 %). The recovery of EPSC 316 
amplitude was best fit by a double exponential under control conditions (10 mM 317 
glucose, fast 226 ± 117 ms (44% amplitude ratio); slow 2.6 ± 2.5 s) but after 20 min of 318 
zero glucose the rapid phase of recovery was lost (Figure 2C), and recovery was 319 
best fit by a slow exponential ( 4.3 ± 0.6 s). In control conditions the EPSC 320 
amplitude fully recovered (94.8 ± 8.4% of first EPSC, t-test, p=0.58), but in the 321 
absence of glucose the EPSC amplitude failed to fully recover by 20 s after the HFS 322 
(61.4 ± 14.9 % of first EPSC, t-test, p=0.048), and remained depressed after 4 min of 323 
rest without stimulation (i.e. between epochs).  324 
The decreased EPSC amplitude could reflect a reduction in either release probability 325 
or in the size of the RRVP. Coefficient of variation (standard deviation/mean) and 326 
variance / mean were calculated to give an indication of which factors are dominant. 327 
EPSC amplitudes were measured to calculate their mean, variance and standard 328 
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deviation at early (3-4 s) and late (29-30 s) segments of the HFS train, since at these 329 
times the EPSC amplitudes were relatively stable.  Mean EPSC amplitude is given 330 
by n.p.q, which has variance = npq2(1-p). Thus the variance/mean = q(1-p) and CV 331 
= std dev/mean = sqrt((1-p)/np). After 20 min without glucose the early coefficient of 332 
variation (0.10 ± 0.01, n=6) was not significantly different from that measured in 333 
control (0.08 ± 0.01, n=4; two-way repeated measures ANOVA, between groups 334 
p=0.008, Bonferroni post hoc p>0.99; Figure 2E left panel). However, the late 335 
coefficient of variation was significantly increased in the zero glucose condition (0.23 336 
± 0.03) compared to control (0.10 ± 0.01, Bonferroni post hoc p=0.01). CV depends 337 
on both n and p (but not q), while var/mean depends on q and p. Since the var/mean 338 
was the same for all (two-way repeated measures ANOVA, between groups p=0.99; 339 
Figure 2E right panel), q and p can be assumed to both be stable across time points 340 
and conditions, hence the increase in CV late in the HFS with zero glucose, must be 341 
due to a decrease in n. This discounts a decrease in release probability as a major 342 
cause of the decrease in EPSC amplitude during HFS, and so the increase in 343 
coefficient of variation in zero glucose is likely caused by a decrease in the RRVP 344 
size. 345 
HFS given after 25 min of continued perfusion of zero glucose resulted in EPSC 346 
failures in 3 out of 4 cells (Figure 2F, timing of failures are indicated by filled 347 
triangles). Throughout these experiments the postsynaptic neurons (that had 348 
maintained ATP from the patch pipette) had stable holding currents (data not 349 
shown). 350 
ATP depletion reduced RRVP size and the number of functional release sites. 351 
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The above experimental data was used to fit a model of transmission at the calyx of 352 
Held from which presynaptic release parameters could be estimated. The model 353 
produced very good fits in both 10 mM (n=4) and zero glucose conditions to the 354 
normalised, averaged EPSC data (n=5, except for 25 min where n=3; Goodness of 355 
fit values all 0.99; Figure 3A-D). The early phase of HFS (0.5 s) was well fit by a 356 
combination of a facilitating release probability, p, and a depressing RRVP size, n, 357 
that recovered at a fast, activity dependent rate (time constant,r0, on the order of 50 358 
msecs; Table 1; Figure 4A-D insets). The identified values for the initial release 359 
probability (P0), facilitation (f) and initial activity-dependent vesicle recovery rate (r0) 360 
were consistent between control and zero glucose conditions and across all epochs 361 
(Table 1). Slow depression of release probability sees p settle at stable values after 362 
around 5 secs of HFS (Figure 4C,D), while the RRVP size, n, continues to decline 363 
due to a slowing of the activity-dependent replenishment rate (Figure 4A,B). The 364 
slowing of replenishment was greatly enhanced in the later epochs in zero glucose 365 
(Figure 4B). The time course of recovery was dominated by the slow recovery of the 366 
release probability, with residual activity-dependent replenishment allowing the 367 
RRVP size to recover quickly. 368 
The model captured the enhanced EPSC depression during HFS as glucose 369 
concentration declined during the sequential epochs (Figure 3B-D) as an increase in 370 
the activity-dependent replenishment time constant, r, resulting in a decrease in the 371 
RRVP size (Figure 4B). This reduction in RRVP size (n) was largely sufficient to 372 
account for the increase in coefficient of variation of EPSC amplitude measured in 373 
the experimental data. The increase in coefficient of variation during HFS at 20 min 374 
in zero glucose (Figure 2E left panel) was consistent with n decreasing by a factor of 375 
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5.3 (assuming release probability or quantal size do not change) and the model 376 
predicted a change of 4.5.  377 
The impaired EPSC recovery following HFS was captured in the model by a 378 
sustained reduction in the maximum RRVP size (functional release sites) where 379 
recovery became increasingly incomplete over the 15, 20 or 25 min epochs (Figure 380 
4B and Table 1).  381 
Vesicular cycling was measured without dialysis of the presynaptic terminal, by 382 
imaging vesicles that were labelled using the styryl dye FM1-43FX, in slices perfused 383 
with 10 mM glucose and zero glucose aCSF (Figure 5A). Vesicles were labelled by 384 
applying FM1-43FX immediately before the 20 min HFS epoch, and the rate of 385 
release was subsequently measured by washing out the dye and imaging at 2 Hz 386 
during the HFS at 25 minutes. We observed a faster rate of release in 10 mM 387 
glucose compare to zero glucose (Figure 5B), consistent with the impaired synaptic 388 
transmission observed while monitoring EPSCs in zero glucose (Figure 2). A 389 
measure of synaptic vesicles labelled with FM1-43FX during the 20 min epoch, was 390 
made after α-Latrotoxin induced FM-destaining following the 25 min HFS to ensure 391 
exocytosis of all labelled vesicles. The ratio of FM-dye fluorescence after α-392 
Latrotoxin over fluorescence after labelling (FLat/F0) is significantly lower for synapses 393 
perfused with 10 mM glucose (n=14) compared with the ones perfused with zero 394 
glucose (n=12, t-test, p<0.001; Figure 5B), suggesting that a smaller number of 395 
vesicles underwent release and endocytosis at the 20 min epoch in zero glucose 396 
compared to 10 mM glucose. 397 
 398 
Reducing presynaptic ATP levels impairs vesicle replenishment 399 
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We have assumed that the mechanism underlying impaired presynaptic function 400 
during glucose depletion was caused by reduced presynaptic ATP; to test this 401 
hypothesis, paired pre- and postsynaptic recordings were performed where the 402 
presynaptic ATP concentration was changed by dialysis from the pipette (while 403 
monitoring synaptic transmission). The experimental paradigm is shown in Figure 6A 404 
and example EPSCs in Figure 6B. 405 
ATP hydrolysis was blocked in the terminal by diffusion of 2.2 mM ATPγS (a non-406 
hydrolysable analog of ATP) from the presynaptic patch pipette and this was 407 
compared to a control condition where the pipette contained 2.2 mM ATP. After 1-2 408 
min of dialysis the depression of EPSC amplitude during HFS was similar with either 409 
ATP or ATPγS in the presynaptic pipette (ATPγS, 51.5 ± 8.2 %, n=5; compared to 410 
ATP, 53.0 ± 9.8 %, n=7; two-way RM-ANOVA, between groups p=0.91, interaction 411 
p=0.16; Figure 6C,D). However, even at this early time-point, the EPSC recovery 412 
was slowed by ATPγS (ATP, 4.4 ± 1.0 s and ATPγS, 12.2 ± 14.4 s) so that EPSC 413 
recovery was significantly impaired in the presence of ATPγS compared to ATP 414 
(two-way RM-ANOVA, between group p<0.01). The EPSC amplitude fully recovered 415 
by 30 s after the end of the HFS with ATP in the patch pipette (85.5 ± 7.9 % of first 416 
EPSC, t-test, p=0.12), but remained significantly depressed with ATPγS in the 417 
pipette (41.3 ± 8.4 % of first EPSC, t-test, p=0.002; Figure 6E). When HFS was 418 
repeated 5 min later, EPSC amplitude had not recovered; the raw EPSC amplitude 419 
at the start of the second HFS was only 0.72 ± 0.32 nA (n=5) with ATPγS, compared 420 
to 4.9 ± 0.8 nA (n=12) with ATP (data not shown). This pharmacological block of 421 
ATP hydrolysis supports the interpretation that the compromised transmission with 422 
glucose depletion was due to lack of ATP.  423 
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To more closely mimic the presynaptic condition occurring with glucose depletion, a 424 
less extreme protocol was required, so presynaptic paired recordings were repeated 425 
and presynaptic ATP lowered from 2.2 to 0.1 mM (without adding ATPγS). The total 426 
adenine nucleotide concentration in the presynaptic pipette was maintained constant 427 
at 2.2 mM (Jolivet et al., 2015), so for the low (0.1 mM) ATP condition, 2.1 mM AMP 428 
was added to the presynaptic pipette. Under these conditions HFS within 1-2 min of 429 
breaking into the presynaptic terminal resulted in an EPSC depression with low ATP 430 
in the pipette (69.0 ± 2.9 %, n=8) that was similar to that with high ATP (53.0 ± 9.8 431 
%, n=7; two-way RM-ANOVA, between groups p=0.12, interaction p=0.45; power 432 
35%, Figure 6F,G). The time course of EPSC amplitude recovery in the low ATP 433 
condition was significantly altered (two-way RM-ANOVA, interaction p<0.001, 434 
between groups p=0.15), but in both high and low ATP conditions EPSC amplitude 435 
had recovered by 30 s after HFS (high ATP alone 85.5 ± 7.9 % of first EPSC, t-test, 436 
p=0.12; low ATP 102.3 ± 4.3 % of first EPSC, t-test, p=0.61; Figure 6H). The 437 
recovery curves were best fit with a single exponential (high ATP  4.4 ± 1.0 s, low 438 
ATP  12.5 ± 2.3s).  HFS was repeated 6-7 min after breaking into the presynaptic 439 
terminal once there had been more time for dialysis to occur. In the low ATP 440 
condition the EPSC depression (85.7 ± 2.2 %, n=12) was significantly increased 441 
compared to the high ATP condition (70.0 ± 2.8 %, n=12; two-way RM-ANOVA, 442 
between groups p<0.001, interaction p=0.17; Figure 6B,I,J). There was a significant 443 
difference between the high and low ATP groups in the magnitude of EPSC 444 
amplitude during recovery (two-way RM-ANOVA, between groups p=0.011; 445 
power=99 %, Figure 6B,K). The recovery curves were best fit with single 446 
exponentials (high ATP  6.9 ± 0.5 s; low ATP 7.4 ± 1.1 s; Fig 6K). EPSC amplitude 447 
failed to fully recover within 30 s after the HFS with low presynaptic ATP (69.2 ± 4.5 448 
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% of first EPSC, t-test, p<0.001), and while the magnitude of the recovery was 449 
greater with high presynaptic ATP the EPSC amplitude failed to fully recover (83.5 ± 450 
5.7 % of first EPSC, t-test, p=0.01). These results indicate that high frequency 451 
transmission and subsequent EPSC recovery require presynaptic ATP, but also that 452 
dialysis of the presynaptic terminal alters vesicle recycling even when a high 453 
concentration of ATP is supplied. 454 
These data therefore confirm that the changes observed in synaptic transmission on 455 
removal of glucose are a consequence of presynaptic ATP depletion from the 456 
terminal with subsequent impaired vesicle recycling. Having set up a means to 457 
investigate metabolic demand in a functional synapse, we asked to what extent other 458 
substrates substitute for glucose and tested the astrocyte-neuron lactate shuttle 459 
(ANLS) hypothesis.  460 
At physiological glucose concentrations the lactate shuttle is required for 461 
maintenance of presynaptic function 462 
We tested whether the lactate shuttle was an important energy source for 463 
presynaptic terminals at physiological glucose concentrations, by blocking lactate 464 
uptake with monocarboxylate transporter (MCT) inhibitors. For these experiments we 465 
returned to only patching the postsynaptic MNTB neuron and using electrical 466 
stimulation of the calyx axons to evoke HFS and recovery pulses at 5 min intervals. 467 
We used a combination of two MCT inhibitors: 200 µM 4-CIN, a competitive MCT2 468 
inhibitor (IC50 24 µM in Xenopus oocytes, Broer et al., 1999), and 1 µM AR-C155858, 469 
a non-competitive MCT1/2 inhibitor that diffuses into cells and binds to the 470 
intracellular domain of the MCTs (Ki 2-10 nM in rat erythrocytes and Xenopus 471 
oocytes, Ovens et al., 2010). This combination of MCT inhibitors was found to be 472 
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effective at blocking transmission supported by lactate in the absence of glucose 473 
(Figure 7). Even in the presence of a high concentration of lactate (10 mM) the MCT 474 
inhibitors reduced the EPSC amplitude to 0.95 ± 0.51 nA (n=3) by 30 min, compared 475 
to an EPSC amplitude of 7.35 ± 1.27 nA (n=4) in 10 mM lactate alone. 476 
In initial experiments, we found that application of MCT inhibitors for 30 mins in the 477 
presence of 10 mM glucose did not significantly increase the EPSC depression 478 
during HFS or reduce the fast component of EPSC recovery (data not shown).  479 
While 10 mM is a standard glucose concentration used for in vitro brain slice 480 
electrophysiology, a more realistic extracellular glucose concentration in the brain is 481 
in the range of 1-2 mM, while lactate levels are around 2-5 mM (Zilberter et al., 482 
2010). We therefore investigated energy substrate use by the presynaptic terminal at 483 
more physiological concentrations by examining whether 1 mM glucose or 1 mM 484 
lactate could maintain presynaptic function and tested the extent to which lactate 485 
shuttled from glial cells contributed to presynaptic energy supply at physiological 486 
glucose concentrations.  487 
After 30 minutes of perfusion with aCSF containing 1 mM glucose the EPSC 488 
depression during HFS (59.5 ± 3.0 %, n=10) was not significantly different to that 489 
with 10 mM glucose (50.9 ± 3.0 %, n=4, two-way RM-ANOVA, between group 490 
p=0.007, Dunnett’s post hoc, p=0.35; power=53 %, Figure 8A,B,F). In the absence of 491 
glucose, 1 mM lactate can maintain synaptic function, with depression of 64.8 ± 7.9 492 
% during HFS (n=4); this was not significantly different to that seen in the presence 493 
of 1 mM glucose (Dunnett’s post hoc p=0.71; power=9 %, Figure 8A,B,F). The next 494 
question was to determine if the presynaptic terminal was using glucose directly or 495 
relying on the lactate shuttle. Perfusion of the MCT inhibitors in the presence of 1 496 
mM glucose depressed EPSCs during HFS by 75.3 ± 3.5 % (n=6), which was 497 
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significantly greater than the depression seen with 1 mM glucose alone (59.5 ± 3.0 498 
%, n=10, Dunnett’s post hoc, p=0.017; power=93 %, Figure 8C,D,F). This suggests 499 
that the presynaptic terminal is using glucose and that additional lactate (presumably 500 
from glial cells) is important for maintaining normal transmission. 501 
The recovery of the EPSC amplitude following HFS was not found to be significantly 502 
different between the 1 mM glucose, 1 mM lactate or 1 mM glucose plus MCT 503 
inhibitor groups (two-way RM-ANOVA, between groups p=0.21, interaction p=0.36; 504 
Figure 8E). In all conditions the EPSC amplitude fully recovered within 20 s after the 505 
end of HFS (1 mM glucose 94.3 ± 6.0 % of first EPSC, t-test, p=0.37; 1 mM lactate 506 
97.2 ± 13.1 % of first EPSC, t-test, p= 0.85; 1 mM glucose plus MCT inhibitors 94.2 ± 507 
7.3 % of first EPSC, t-test, p=0.46). In all conditions the recovery was best fit by a 508 
double exponential (1 mM glucose fast 310 ± 47 ms, 31 %, slow 5.8 ± 10.6; 1 mM 509 
lactate fast 277 ± 31 ms, 32 %, slow 5.9 ± 0.3 s; 1 mM glucose with the MCT 510 
inhibitors in the presence of 1 mM glucose fast 193 ± 62 ms, 23 %, slow 5.5 ± 0.6 s).  511 
Recovery curves are generally fit to the mean EPSC amplitudes due to the large 512 
degree of variability in individual experiments.  However, this generalisation masks 513 
elements of the physiological response, so for the mean recovery curves shown in 514 
Figure 8E, we have re-plotted each individual recovery curve for each experiment in 515 
Figures 9A-D. In the 1 mM glucose the recovery curves were best fit by a double 516 
exponential in 8 out of 10 cases (Figure 9A, with 9B showing the fast component up 517 
to 2.5 s), in two cases (indicated by black squares) only a single slow component 518 
was observed. Similarly, in 1 mM glucose with the MCT inhibitors the best fit was a 519 
double exponential in 5 out 6 experiments (Figure 9C); again the one cell which 520 
could not be fit by a double exponential is shown with black squares. In the 1 mM 521 
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lactate experiment, all four cases could be fit to a double exponential (Figure 9D). 522 
We show this data to justify exclusion of those small number of cases where the 523 
recovery curve is not fit by a double exponential, which then allows analysis of the 524 
fast and slow components of recovery. Analysing only the double exponential 525 
recovery curves, the percentage of fast recovery was significantly reduced in the 526 
presence of the MCT inhibitors (25.3 ± 3.3 %, n=5) compared to 1 mM glucose (50.0 527 
± 5.5 %, n=8, one-way ANOVA p= 0.02, Dunnett’s post hoc p=0.01; Figure 9E), 528 
consistent with a presynaptic contribution by metabolism of lactate under low 529 
glucose conditions. There was no significant difference in the percentage of fast 530 
recovery between 1 mM lactate (33.8 ± 8.4 %, n=4) compared to 1 mM glucose 531 
(Dunnett’s post hoc p=0.14; Figure 9E). The value of the fast time constant was the 532 
same across all experimental conditions (1 mM glucose 440 ± 163 ms, 1 mM 533 
glucose plus MCT inhibitors 167 ± 43 ms, 1 mM lactate 342 ± 127 ms, one-way 534 
ANOVA p=0.42; Figure 9F). Similarly, the slow time constant was unchanged across 535 
all conditions (1 mM glucose 7.4 ± 1.6 s, 1 mM glucose plus MCT inhibitors 4.5 ± 2.0 536 
s, 1 mM lactate 7.3 ± 1.9 s, one-way ANOVA p=0.48; Figure 9G). We conclude that 537 
the underlying recycling processes were unchanged across these conditions, and 538 
that loss of lactate as a presynaptic substrate (by blocking uptake) reduced ATP 539 
availability and that this was reflected in a reduced fast activity-dependent recovery.   540 
Under low ATP conditions the Thr172 residue of AMP kinase is phosphorylated, so 541 
phospho-Thr172-AMPK is used as an indicator of metabolic stress (Hardie et al., 542 
2012). We tested for evidence of metabolic stress using western blotting from slices 543 
that had been used for electrophysiology.  In slices treated with 1 mM glucose (for 40 544 
min) there was increased AMPK Thr172 phosphorylation compared to slices treated 545 
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with 10 mM glucose (Figure 8G) and the addition of the MCT inhibitors in the 546 
presence of 1 mM glucose did not further increase AMPK phosphorylation.  547 
To determine whether the lactate supporting presynaptic function was generated 548 
from glucose or the result of glycogen breakdown within glial cells, we applied the 549 
glycogenolysis inhibitor, 1,4-dideoxy-1,4-imino-d-arabinitol (DAB, 500 µM), in the 550 
presence of 1 mM glucose. We found no effect of DAB on the magnitude of EPSC 551 
depression during HFS (43.5 ± 5.3 %, n=4) when compared to glucose alone (49.3 ± 552 
3.3 % n=4; two-way RM-ANOVA, between groups p=0.38, interaction p=0.88, 553 
power=15 %, Figure 10A,B,D). Furthermore, there was no significant effect on the 554 
EPSC amplitude during the recovery period (two-way RM-ANOVA, between groups 555 
p=0.86, interaction p=0.20), and the recovery curve in the presence of 1 mM glucose 556 
plus DAB was fit by a double exponential (fast 157 ± 25 ms, 59 %, slow 7.8 ± 2.6 s, 557 
Figure 10C). We conclude that there is no detectable contribution from 558 
glycogenolysis when glucose in available in the aCSF. 559 
Lactate produced from glycogenolysis in glial cells helps support presynaptic 560 
function in extreme glucose deprivation.  561 
Lactate contributes to maintaining synaptic transmission in low glucose, but what 562 
happens during more severe energy deprivation, such as when glucose was being 563 
completely depleted? Synaptic transmission was maintained for 15 min during 564 
perfusion of an aCSF containing zero glucose and zero lactate. The EPSC 565 
depression was 45.2 ± 4.6 % during HFS (n=6; Figure 11A,B), but the addition of 566 
MCT inhibitors (in the same zero glucose/lactate aCSF) significantly increased the 567 
magnitude of the EPSC depression to 65.4 ± 4.0 % (n=6, two-way RM-ANOVA, 568 
between groups p=0.01, Bonferroni post hoc, p=0.01). Perfusion of the 569 
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glycogenolysis inhibitor (500 µM DAB, in zero glucose/lactate aCSF) increased the 570 
magnitude of EPSC depression to 62.3 ± 4.1 % (n=7, Bonferroni post hoc, p=0.03; 571 
power=79 %, Figure 11A,B,D). There was no significant difference in the EPSC 572 
depression between the MCT inhibitor and DAB groups (Bonferroni post hoc, 573 
p>0.99). The EPSC recovery phase in zero glucose/lactate aCSF maintained both 574 
fast 142 ± 34 ms (30 %) and slow 2.7 ± 0.3 s components; and was not significantly 575 
different on addition of MCT inhibitors (fast 201 ± 88 ms, 15 %; slow 9.4 ± 1.1 s; 576 
Figure 11C) or DAB (τfast 351 ± 85 ms, 31 %; τslow 7.4 ± 0.8 s; two-way RM-ANOVA, 577 
between group p=0.084, interaction p=0.64). The HFS epochs were continued every 578 
5 mins (beyond this 15 mins time point) until EPSC failures started to occur. In the 579 
DAB condition, but not with the MCT inhibitors, the first EPSC failure occurred earlier 580 
than with zero glucose alone (one-way ANOVA, p= 0.033; Bonferroni post hocs, 581 
DAB p=0.03, MCT inhibitors p=0.50; Figure 11E). We conclude that during glucose 582 
deprivation lactate can help to maintain presynaptic function in the short-term, with 583 
the lactate being generated by the breakdown of stored glycogen.  584 
Discussion 585 
We have employed the calyx of Held/MNTB synapse to investigate how energy 586 
substrate availability and presynaptic ATP influence synaptic transmission. Synaptic 587 
transmission declines and eventually fails following glucose depletion. Dialysis of the 588 
presynaptic terminal with low ATP confirmed that the impaired transmission following 589 
glucose removal is caused by presynaptic ATP depletion. Model-based analysis of 590 
synaptic transmission indicated that glucose depletion slowed activity-dependent 591 
vesicle replenishment and reduced the number of functional release sites, resulting 592 
in a smaller resting RRVP size. When extracellular glucose is within the physiological 593 
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range (1 mM) the presynaptic terminal uses glucose and lactate. Glycogenolysis also 594 
contributes to the maintenance of synaptic transmission during glucose deprivation 595 
(Figure 12).  596 
Presynaptic ATP depletion impairs presynaptic function 597 
At the calyx of Held/MNTB synapse HFS generates a well characterised short-term 598 
synaptic depression, which is one way of reducing metabolic cost during prolonged 599 
transmission (Billups et al., 2005; von Gersdorff and Borst, 2002). Sustained HFS in 600 
the presence of 10 mM glucose caused an initial rapid depression in the EPSC 601 
amplitude followed by a period of relatively stable low amplitude EPSC transmission, 602 
which subsequently recovered to the initial EPSC amplitude. Twenty minutes after 603 
the removal of glucose, EPSC depression increased towards the end of the HFS 604 
train and recovery was impaired. Energy deprivation would eventually influence the 605 
postsynaptic resting membrane potential and conductance (Akasu et al., 1996; 606 
Calabresi et al., 1997), but in our experiments ATP was provided in the postsynaptic 607 
patch pipette, thereby eliminating postsynaptic effects while permitting depletion of 608 
the presynaptic terminal. Repeating HFS epochs over a period of 25 min without 609 
glucose caused a progressive decline in EPSC amplitude and failure of transmission.  610 
Dialysis of ATPγS into the presynaptic terminal rapidly blocked all ATP usage. A 611 
more subtle control of presynaptic ATP was achieved by dialysis of the terminal with 612 
low ATP, this condition increased EPSC depression during HFS and impaired the 613 
subsequent recovery, similar to glucose deprivation. These results confirm that the 614 
effects of glucose deprivation were caused by presynaptic energy depletion and 615 
reduced glutamate release. This is consistent with glucose deprivation in other brain 616 
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regions where transmission is impaired by a reduction in transmitter release (Akasu 617 
et al., 1996; Calabresi et al., 1997; Izumi et al., 1997). 618 
 619 
Energy deprivation reduces the number of functional release sites and rate of vesicle 620 
replenishment. 621 
Analysis of the data and fit to the computational model suggests the reduction in 622 
synaptic transmission with ATP depletion is due to slowed activity-dependent 623 
replenishment of the RRVP during HFS and a decreased number of functional 624 
release sites, resulting in a reduced resting RRVP size following recovery (Figure 9). 625 
Reductions in vesicle release probability cannot account for EPSC amplitude 626 
changes since there was no change in the variance/mean ratio of EPSC amplitudes 627 
during the HFS. The initial release probability (Po) early in the HFS was unchanged 628 
in the absence of glucose, consistent with there being sufficient time (4 minutes) and 629 
ATP availability to recover the release probability between HFS epochs. This 630 
contrasts with a previous study where glucose deprivation decreased the release 631 
probability in corticostriatal synapses (Calabresi et al., 1997).  632 
The increased activity-dependent RRVP replenishment time constant, r, is the major 633 
factor contributing to the increased EPSC depression during HFS in zero glucose. 634 
This is consistent with the loss of the fast activity-dependent component from the 635 
EPSC recovery curve after 20 min of zero glucose (Figure 2D), which corresponds 636 
with the slow release pool previously observed at the calyx and blocked by ATPγS 637 
(Neher, 2017; Sakaba and Neher, 2003). Furthermore, when the presynaptic 638 
terminal was dialysed with low ATP the first change was a slowing of recovery 639 
(Figure 6H), and block of presynaptic lactate uptake by MCT inhibitors reduced the 640 
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contribution by the fast recovery phase (Figure 8E, Figure 9), suggesting that 641 
activity-dependent vesicle replenishment is particularly sensitive to reduced 642 
presynaptic ATP.   643 
The model identified a reduced size of the maximal RRVP as underlying the failure 644 
of the EPSC to fully recover between HFS trains with glucose deprivation. This is 645 
interpreted as an increase in the number of release sites lacking primed vesicles, 646 
which could arise by the slowing of multiple ATP-dependent processes, including 647 
vesicle priming and recycling. When glucose was removed, the imaging results 648 
suggest that endocytosis is particularly susceptible to energy depletion, while 649 
exocytosis is less so; this fits with previous findings that endocytosis is a particularly 650 
energy demanding process (Rangaraju et al., 2014; Pathak et al., 2015). 651 
 652 
 653 
The action potential waveform is also capable of influencing transmitter release. 654 
The relationship between presynaptic action potential waveform, calcium influx and 655 
transmitter release at the calyx of Held is well characterized and detailed (Borst & 656 
Sakmann, 1998; Kochubey et al., 2009; Yang & Wang, 2006; for reviews see von 657 
Gersdorff & Borst 2002; Schneggenburger & Forsythe, 2006). Changes in 658 
presynaptic AP waveform have been observed following blockade of potassium 659 
currents (Wang & Kaczmarek, 1998) in studies of activity-dependent vesicle 660 
recycling, and with activity-dependent modulation of presynaptic potassium currents 661 
at mossy fibres (Geiger & Jonas, 2000). Recent observations during resting 662 
conditions and low frequency stimulation (Lujan et al., 2016) support the idea that 663 
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pharmacological block of glycolysis affects transmitter release by depolarization 664 
(implying rundown of ionic gradients) and slowing of the presynaptic AP waveform. 665 
In the research reported in this paper, we have explored synaptic transmission under 666 
quasi-physiological conditions (in vitro) and induced a metabolic stress by 667 
exchanging extracellular metabolic substrates and induction of high frequency 668 
stimulation (with 3000 action potentials). Additionally, for the presynaptic recordings 669 
reported here, the ‘action potential’ was a voltage-clamp command and intracellular 670 
ionic concentrations were maintained by dialysis of the terminal from the patch 671 
pipette, so the changes in transmitter release observed with reduced ATP 672 
concentrations were not due to changes in AP waveform.  This shows that 673 
mechanisms other than changes in AP waveform must also contribute, and we 674 
demonstrated that changes in neurotransmitter release parameters are observed on 675 
ATP depletion during high frequency stimulation.  676 
 677 
Presynaptic terminals can utilise both glucose and lactate.   678 
The ANLS hypothesis has stimulated considerable debate (Dienel, 2012; Pellerin 679 
and Magistretti, 2012). It postulates that during neuronal activity, when energy 680 
demand is high, glucose is preferentially metabolised by glial cells to lactate and this 681 
lactate is shuttled to neurons to meet neuronal metabolic demands (Pellerin and 682 
Magistretti, 1994). Many ANLS studies have been conducted in tissue culture, but 683 
the MNTB brain slice preparation has the advantage of maintaining association 684 
between the presynaptic calyx, its target neuron and glial cell (Uwechue et al., 2012).  685 
Izumi et al. (1997) found that lactate can fully support synaptic transmission, while 686 
others found 20 mM lactate could only partially substitute for glucose (Nagase et al., 687 
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2014). We found that 1 mM lactate, which is within physiological ranges (Zilberter et 688 
al., 2010) can be metabolised by the terminal to sustain presynaptic function. 689 
Oxidative phosphorylation is the major energy source in the brain (Hall et al., 2012; 690 
Harris et al., 2012) with glucose metabolism rising with brain activity to drive local 691 
ATP synthesis (Rangaraju et al., 2014).  Recent studies have suggested that 692 
glycolysis is very significant in nerve terminal metabolism (Ashrafi & Ryan, 2017; 693 
Lujan et al., 2016) and that neuronal activity increases Glut4 glucose transporters in 694 
presynaptic membranes (Ashrafi et al., 2017) via AMPK signalling, thereby raising 695 
intracellular pyruvate as a substrate for Krebs cycle.  696 
 697 
The results demonstrate that when glucose is around physiological levels (1 mM) 698 
presynaptic terminals can utilise both glucose and lactate and that metabolic 699 
compromise during neuronal activity can limit the efficacy of synaptic transmission. 700 
Phosphorylation of AMPK-Thr172 did not increase when lactate uptake was blocked, 701 
suggesting that there was no further metabolic stress in the absence of lactate, but 702 
any further change may have been occluded through AMPK activation on reducing 703 
glucose from 10 to 1 mM. The ability to use both glucose and shuttled lactate will 704 
confer a physiological advantage where metabolic demands are high. In 705 
hippocampal slices the ANLS did contribute to maintaining synaptic transmission in 706 
slices exposed to low (2 mM), but not higher glucose concentrations (Izumi et al., 707 
1997). Another study suggested that the ANLS is required for fully functional 708 
synaptic transmission (Nagase et al., 2014), however, 1 mM of the MCT inhibitor 4-709 
CIN used in that study would be sufficient to also disrupt mitochondrial pyruvate 710 




Glycogen is implicated as an energy source under physiological conditions (Suzuki 713 
et al., 2011; Brown et al., 2003). We found no evidence for glycogenolysis when 714 
neurons were supplied with 1 mM glucose, but during severe glucose deprivation 715 
MCT inhibitors and glycogenolysis inhibitors independently reduced synaptic 716 
transmission to a similar extent. In the brain, glycogen and glycogen phosphorylase 717 
(the enzyme required for glycogenolysis) are only found in glial cells (Cataldo and 718 
Broadwell, 1986; Pfeiffer et al., 1992). Our result under extreme glucose deprivation 719 
is consistent with lactate being produced by glial cells from the hydrolysis of 720 
glycogen stores to maintain synaptic transmission. Increases in the AMP:ATP ratio 721 
activate glycogen phosphorylase (Obel et al., 2012), consistent with glycogen acting 722 
as a short-term energy reserve to maintain neuronal transmission during glucose 723 
deprivation (Brown et al., 2003; Shetty et al., 2012). Alternatively, glial generation of 724 
lactate from glycogen could preserve extracellular glucose for neurons rather than 725 
generate lactate for neuronal use (DiNuzzo et al., 2010). 726 
We demonstrate that excitatory synaptic terminals use glucose and lactate 727 
generated during glucose deprivation, consistent with lactate shuttling under 728 
conditions of metabolic stress. The experimental paradigms developed here to 729 
investigate presynaptic metabolic substrates in a physiological system show clear 730 
changes in synaptic transmission when energy supply is compromised or while 731 
sustaining high transmission rates. When energy resources become scarce 732 
modulation of presynaptic function may reduce metabolic demand, but will also 733 
compromise information transmission; the interplay between these signalling and 734 
metabolic pathways will provide insights to improve cognition following brain injury, 735 
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Figure/Table legends 892 
 893 
Figure 1.  The paradigm to investigate presynaptic metabolic influence on 894 
transmission at the calyx of Held synapse, in vitro.  895 
(A) The recording configuration showing bipolar stimulation of the presynaptic axon 896 
and patch recording of EPSCs from the postsynaptic MNTB neuron under whole-cell 897 
voltage clamp.  Metabolism in the postsynaptic MNTB neuron is maintained by ATP 898 
through dialysis from the patch pipette.  899 
(B) One epoch of high frequency stimulation (HFS, 50 s duration) consisted of a 30 s 900 
100 Hz train, and a 20 s recovery phase of 6 stimuli (lower trace), the 3000 EPSCs 901 
from this train are plotted (middle trace) and single EPSC traces for the first and last 902 
EPSCs of the HFS train are plotted (top).  The 6 Recovery EPSCs are plotted 903 
superimposed (with latencies after the HFS indicated in seconds) illustrating the 904 
recovery period.   905 
(C) The percent EPSC amplitude is plotted normalised to the first EPSC, for one 30 s 906 
HFS (in standard recording conditions, 10 mM glucose). The initial rapid depression 907 
of EPSC amplitude over the first 0.1 s is shown in the inset; and EPSC amplitude is 908 
maintained at around 40% of the initial amplitude for the remainder of the HFS.  909 
(D) The recovery of EPSC amplitude over 20 s following the end of HFS (in standard 910 
recording conditions, 10 mM glucose) shows full recovery within 20 s. 911 
(E & F) HFS epochs were repeated at 5 minute intervals while recording over a 912 
period of 25 minutes.  The mean EPSC amplitude (nA, not normalised) is plotted for 913 
the first and last EPSC of each HFS (filled circles) and for each of the recovery 914 
EPSCs (open circles) for control conditions with 10 mM extracellular glucose (E, 915 
n=4) and for zero extracellular glucose (F, n=5, except at 10 min where n=4).  (E) For 916 
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the 10 mM glucose condition, EPSC amplitude recovers after each HFS and 917 
continues to do for each subsequent HFS epochs. (F) In zero glucose good recovery 918 
is observed after the first HFS epoch, but is increasingly compromised and 919 
incomplete during subsequent epochs, giving a progressive reduction in EPSC over 920 
time; so that there is little recovery from the third HFS epoch by 25 min (far right, 921 
black arrows) in the absence of glucose.  Pooled data, mean ± SEM. 922 
 923 
Figure 2. Removal of glucose increases EPSC depression during HFS and 924 
impairs subsequent EPSC recovery.  925 
 (A) Raw EPSC amplitudes during a HFS epoch after 20 minutes in either 10 mM 926 
glucose (grey, n=4) or zero glucose (black, n=6). Left inset shows EPSC amplitudes 927 
for the first 0.1 s of the HFS. Right inset shows the potential sources of presynaptic 928 
metabolic substrate.  929 
(B) The same data as A, under both conditions normalised to the amplitude of the 930 
first EPSC and pooled (mean ± SEM). Left inset shows mean normalised EPSC 931 
amplitude for the first 0.1 s of the HFS. Right inset shows example traces of the first 932 
5 EPSCs. 933 
(C) Mean % normalised EPSC recovery curve at 20 minutes for 10 mM glucose and 934 
the impaired recovery after 20 min of zero glucose.  935 
(D) Traces from one example after 20 min of zero glucose (top trace) showing 50 s 936 
HFS epoch and recovery. Single EPSC traces for the first and last EPSCs in the 937 
same HFS train are shown with 6 superimposed EPSCs (at the indicated latencies 938 
after the HFS) illustrating the recovery period.   939 
(E) After 20 min of perfusion with either 10 mM glucose or zero glucose the 940 
coefficient of variation of the EPSCs was not different early in the HFS (3-4 s), but 941 
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was increased at the end of HFS (29-30 s) in the zero glucose condition (left panel). 942 
No change was seen in variance/mean between the two conditions at either time 943 
point (right panel). 944 
(F) After 25 min of zero glucose EPSC failures were observed in three out of the 4 945 
synaptic pairs studied; while no failures were observed in 10 mM glucose. In zero 946 
glucose the raw EPSC amplitude was further reduced and the magnitude of 947 
depression increased during HFS. The first failure for each recording is indicated by 948 
the black triangle.  Left inset shows EPSC amplitudes for the first 0.1 s of the HFS. 949 
Right inset shows example traces of the first 5 EPSCs in each HFS train. 950 
 951 
Figure 3. Model data fits well to experimental recordings. 952 
The fit of the model (10 mM glucose in blue; zero glucose in red) to transmission in 953 
the two experimental conditions is overlaid with the mean experimental data (zero 954 
glucose in black, n=5 (25 min n=3); 10 mM glucose in grey, n=4) for four HFS 955 
epochs recorded at (A) 10 min, (B) 15 min, (C) 20 min and (D) 25 min. The model 956 
was fit to the 30 s HFS and the 20 s recovery period. Insets show the model fit and 957 
mean experimental data over the first 0.5 s of the experimental recordings. With 958 
increasing time, the zero glucose condition showed increased depression during the 959 
HFS (0-30 s) and slowed recovery in amplitude during the recovery phase (30-50 s).  960 
 961 
Figure 4. The model parameters during glucose washout are consistent with a 962 
reduced number of functional release sites. 963 
Plots of n (number of functional release sites) and p (release probability) model 964 
parameters for control 10 mM glucose (A & C) and zero glucose conditions (B & D) 965 
over the 10-25 mins of HFS epochs (10 – black, 15 - grey, 20 - blue, 25 - red).       966 
41 
 
(A) Decrease in the number of functional release sites (n) during HFS in aCSF 967 
containing 10 mM glucose. The relative change in the model parameter n (Initially 968 
n=1) from the beginning of each HFS epoch against time (s) is shown. The value of n 969 
is unchanged across all epochs. (B) Relative change in n during washout of glucose 970 
(zero glucose aCSF).  In zero glucose, n decreases further and recovers more slowly 971 
during subsequent HFS trains (15, 20 and 25 min).  972 
(C) Although variable between epochs, no consistent change in release probability 973 
(p) was observed during each sequential HFS epoch (10, 15, 20, 25 min) in 10 mM 974 
glucose or (D) zero glucose. 975 
 976 
Figure 5. Suppressed uptake of FM1-43 fluorescence following HFS during 977 
washout of glucose.  978 
(A) Representative images of calyx of Held synapses labelled with FM1-43FX; 979 
labelling of vesicles in the presynaptic calyx is shown in green surrounding a central 980 
unstained (black) MNTB neuron. Left column shows 10 mM glucose the right column 981 
shows zero glucose before HFS (top), after HFS (middle) and after 2 min application 982 
of α-Latrotoxin (bottom). Scale bar 10 μm. 983 
(B) Summary graph of FM1-43FX fluorescence intensity plotted over time during the 984 
25 min HFS (black bar) for calyces from slices perfused with 10 mM glucose (grey, 985 
n= 14) and zero glucose (black, n= 12). Inset: ratios of fluorescence intensity after 986 
Lat application over initial FM-dye fluorescence for calyces perfused in 10 mM 987 
glucose (grey, n= 14) and zero glucose (black, n= 12) show reduced vesicle 988 
recycling in the zero glucose condition.  989 
 990 
   991 
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Figure 6. Presynaptic dialysis with ATPS or low ATP enhances synaptic 992 
depression during HFS and impairs the subsequent EPSC recovery.   993 
(A) Schematic of paired presynaptic and postsynaptic recording configuration (upper 994 
left) with the three ATP conditions for the presynaptic dialysis. ATP was always 995 
present in postsynaptic recordings. A voltage ramp (upper right) was applied to the 996 
presynaptic terminal to mimic an action potential and trigger transmitter release; the 997 
voltage ramp was applied to generate the HFS EPSC trains (100Hz, 2 sec) and the 998 
pulses to follow recovery (lower panel).  999 
(B) Example EPSC traces recorded after 6-7 min presynaptic dialysis with high (2.2 1000 
mM) ATP (grey) or low (0.1 mM) ATP (red); the upper traces show full stimulation 1001 
and recovery sweeps and the lower traces show the first and last EPSCs in the train 1002 
(before recovery).  1003 
Data are presented to aid comparison as mean ± SEM in a 3x3 matrix of plots. The 1004 
columns: (C,F,I) Left - shows the mean raw EPSC amplitudes during the train; 1005 
(D,G,J) Middle – shows the same data normalised to the amplitude of the first EPSC 1006 
(100%); (E,H,K) Right – Normalised EPSC as % recovery curves.  1007 
The rows show the three experimental conditions:  1008 
(C,D,E) Top -  ATPγS (blue) versus ATP (grey) within 2 minutes of going ‘whole-1009 
terminal’. This shows that dialysis with either ATPγS or ATP for 1-2 minutes gave 1010 
similar EPSC depression during the HFS, but the EPSC never recovered in the 1011 
presence of ATPγS. 1012 
(F,G,H) Middle – Low ATP (red) vs high ATP (grey) at 1-2 minutes of going ‘whole-1013 
terminal’. Both ATP conditions gave a similar EPSC depression during the HFS; but 1014 
recovery was slowed in the low ATP condition. 1015 
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 (I,J,K) Bottom – Low ATP vs high ATP after 6-7 minutes of dialysis. Longer dialysis 1016 
with low ATP showed significant enhanced EPSC depression during the HFS and 1017 
incomplete recovery afterwards. 1018 
 1019 
Figure 7. Combined application of two MCT inhibitors generated an effective 1020 
block of lactate uptake into the presynaptic terminal.  1021 
Slices were perfused with 10 mM lactate in the absence of glucose, with (grey) and 1022 
without (blue) the monocarboxylate transporter (MCT) inhibitors 4-CIN (200 µM) and 1023 
AR-C155858 (1 µM). The ability to sustain HFS EPSC trains was assessed at 10 1024 
and 30 minutes. 1025 
(A) 10 min: the raw EPSC amplitude during HFS was not significantly different 1026 
following perfusion with lactate alone or lactate plus MCT inhibitors. Insets show 1027 
EPSC amplitude for the first 0.1 s of HFS and example traces show the first 5 1028 
EPSCs of the HFS. 1029 
(B) 30 min: the raw EPSC amplitude during HFS was maintained with 10 mM lactate 1030 
alone, but greatly reduced by addition of the MCT inhibitors with EPSC failures 1031 
during the HFS in 1 of the 3 recordings.  1032 
 1033 
Figure 8. Presynaptic terminals can utilise glucose or lactate to maintain 1034 
synaptic transmission.  1035 
(A) Raw EPSC amplitudes and (B) mean normalised EPSC amplitudes plotted 1036 
during HFS show that the magnitude of EPSC depression was similar after 30 min 1037 
perfusion with either 1 mM glucose (grey) or 1 mM lactate (blue) alone. (A inset) Left 1038 
plot shows the first 0.1 s of HFS. Right inset shows the experimental conditions. (B 1039 
inset) Left plot shows the normalised EPSC amplitudes for the first 0.1 s of HFS. 1040 
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Right plot shows example traces of the first 5 EPSCs of HFS using glucose or lactate 1041 
as the sole presynaptic metabolic substrate.  1042 
(C) Raw EPSC amplitudes and (D) mean normalised EPSC amplitudes during HFS 1043 
after 30 min of perfusion with 1 mM glucose alone (grey) and 1 mM glucose plus the 1044 
monocarboxylate transporter (MCT) inhibitors (red; 4-CIN, 200 µM + AR-C155858, 1 1045 
µM). The MCT inhibitors significantly enhanced EPSC depression.  (C inset) the left 1046 
plot shows EPSC amplitudes for the first 0.1 s of HFS. The right inset shows the 1047 
experimental conditions. (D inset) Left plot shows is the EPSC amplitudes for the first 1048 
0.1 s of HFS. Right plot shows example traces of the first 5 EPSC of HFS.  1049 
 (E) EPSC amplitude fully recovers following HFS in the presence of 1 mM glucose, 1050 
1 mM lactate or 1 mM glucose plus MCT inhibitors, however see figure 9.  1051 
(F) Summary of the average EPSC amplitude during HFS. For each individual 1052 
recording every 100th EPSC of HFS (i.e. 30 EPSCs in total) was averaged, these are 1053 
the EPSCs used for statistical analysis (RM-ANOVA).  1054 
(G) Western blots show increased AMP kinase and phosphorylated AMP kinase 1055 
(Thr172), in slices perfused with 1 mM glucose compared to 10 mM glucose. 1 mM 1056 
glucose plus MCT inhibitors gave no further increase in AMPK or Thr172 pAMPK.  1057 
 1058 
Figure 9. Analysis of individual recovery curves reveals that MCT inhibitors 1059 
reduce the contribution of fast EPSC recovery in 1 mM glucose. 1060 
Individual recovery curves from single calyx of Held synapses (indicated by the 1061 
different colours) from the 30 min HFS epoch while being perfused with one of three 1062 
different substrate conditions.  1063 
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(A & B) 1 mM glucose, (C) 1 mM glucose plus MCT inhibitors and (D) 1 mM lactate. 1064 
Data in black squares/lines in A-C show curves that could not be fit by a double 1065 
exponential and have been excluded from subsequent analysis.  1066 
(E) Plot of percentage amplitude contribution by the fast recovery time constant; this 1067 
was significantly reduced by MCT inhibitors. There was no difference between the 1 1068 
mM lactate and 1 mM glucose conditions. 1069 
(F) The value of the fast time constant of recovery was not significantly different 1070 
between with the three conditions: 1 mM glucose, 1 mM glucose plus MCT inhibitors 1071 
or 1 mM lactate. 1072 
(G) The value of the slow time constant of recovery was not significantly different 1073 
between with the three conditions: 1 mM glucose, 1 mM glucose plus MCT inhibitors 1074 
or 1 mM lactate. 1075 
 1076 
 1077 
Figure 10. Glycogenolysis makes no contribution to presynaptic metabolism in 1078 
the presence of 1 mM extracellular glucose. 1079 
(A) Raw EPSC amplitudes and (B) normalised mean EPSC amplitudes during HFS 1080 
show that after 30 min of perfusion with 1 mM glucose plus the glycogenolysis 1081 
inhibitor (black; DAB, 500 µM) there was no difference in EPSC depression 1082 
compared to with 1 mM glucose alone (grey). Insets show the first 0.1 s of HFS and 1083 
example EPSC traces show the first 5 EPSCs of HFS.  1084 
(C) The addition of DAB in the presence of 1 mM of glucose had no effect on the 1085 
EPSC recovery curve.  1086 
(D) Summary showing the average EPSC amplitude during the 30 s of HFS was 1087 




Figure 11. Glycogenolysis can contribute to maintenance of synaptic 1090 
transmission during washout of glucose.  1091 
(A) Raw EPSC amplitudes and (B) normalised mean EPSC amplitudes during HFS , 1092 
show that after 15 min of perfusion with 0 mM glucose plus MCT inhibitors (red; 200 1093 
µM 4-CIN + 1 µM AR-C155858) or 0 mM glucose plus the glycogenolysis inhibitor 1094 
(black; 500 µM DAB) there was increased EPSC depression compared to with 0 mM 1095 
glucose alone (grey). Insets show the first 0.1 s of HFS and example EPSC traces 1096 
give the first 5 EPSCs of HFS.  1097 
(C) The addition of the MCT inhibitors or DAB in the absence of glucose did not 1098 
change the recovery.  1099 
(D) Summary of the average EPSC amplitude during the 30 s of HFS at 15 minutes 1100 
exposure show that both MCT inhibitors and DAB cause a significant reduction in 1101 
EPSC amplitude.  1102 
(E) Delivery of HFS epochs was continued beyond 15 minutes and the number of 1103 
stimuli delivered (3000 per HFS train) before observation of the first transmission 1104 




Figure 12. Summary diagram showing the route of metabolic substrate 1109 
utilisation by the presynaptic terminal and the effects of ATP depletion on 1110 
transmitter release.  1111 
Under physiological conditions the presynaptic terminal will use glucose directly, and 1112 
could also utilise local lactate made by glial cells. During glucose deprivation some 1113 
energy is supplied in the form of the lactate from glycogen breakdown in the glial 1114 
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cells. ATP depletion did not primarily effect vesicle release probability, but slowed 1115 
vesicle replenishment and reduced the number of release sites possessing 1116 
releasable vesicles, a reduction in endocytosis and vesicle recycling rates may also  1117 
contribute to compromised transmission. 1118 
 1119 
  Table 1 1120 
 1121 
 1122 
Table 1. Model parameter values. 1123 
Model parameter values obtained from fitting to the mean data in 10 mM glucose 1124 








15 min 20 min 25 min 10 min 15 min 20 min 25 min 
r0 (s) 0.042 0.039 0.044 0.042 0.045 0.040 0.051 0.063 
f (s) 0.010 0.021 0.010 0.010 0.010 0.035 0.056 0.019 
Po 
0.163 0.178 0.128 0.131 0.133 0.192 0.176 0.199 
kf (fixed) 0.030 0.030 0.030 0.030 0.030 0.030 0.030 0.030 
An 0.440 0.412 0.454 0.417 0.538 0.264 0.085 0.045 
n (s) 10.978 9.712 11.844 10.570 11.709 12.068 13.115 8.674 
kn 6.318 7.014 5.428 6.187 2.699 8.500 3.890 2.571 
I (s)  2.089 2.546 2.906 2.318 3.342 0.813 12.175 3.696 
ki 0.0023 0.0017 0.0015 0.0017 0.0018 0.0033 0.0026 0.0026 
rR (s) 2.907 2.821 2.755 1.952 6.674 1.499 2.187 3.608 
rD (s) 2.546 1.621 1.194 1.351 0.707 1.216 0.747 1.149 
nRec 0.828 0.875 0.920 0.877 1.085 0.653 0.634 0.063 
48 
 
Additional Information 1128 
 1129 
The authors declare no competing interests. 1130 
All authors have approved the final version of the MS and agree to be accountable 1131 
for the work. Only authors that qualify for authorship have been listed. 1132 
 1133 
Funding is stated on Page 1 1134 
 1135 
Author Contributions: 1136 
SL: Expt design, electrophysiology and imaging acquisition and analysis, MS drafting 1137 
and revision. 1138 
CBM: Modelling, analysis, MS drafting. 1139 
VM: Expt design, analysis, MS drafting. 1140 
JLS: Western blot acquisition and analysis, MS drafting. 1141 
MHH: Expt and modelling design and interpretation, MS drafting and revision. 1142 
BG: Expt and modelling design and interpretation, MS drafting and revision. 1143 
IDF: Expt Design, interpretation, MS drafting and revision. 1144 












